BillionToOne logo

BillionToOne

A diagnostic DNA testing company using quantified biological data.

9

Funding Rounds

$276.0m

Money raised

Overview

A diagnostic DNA testing company using quantified biological data.

Funding

Funding series

Funding Series Analysis

The company BillionToOne has raised a total of $212.4m in funding over 9 rounds.

Key Insights:

  • BillionToOne , March 2022: $125m
  • BillionToOne Series B round, July 2021: $55m
  • BillionToOne Series A round, March 2019: $15m
  • BillionToOne funding round, April 2019: $15m
  • BillionToOne Seed round, September 2017: $2.4m
  • BillionToOne Series C round, December 2022: $48.5m
  • BillionToOne Series A round, March 2020: $15m
  • BillionToOne Seed round, August 2017: $120k
BillionToOne logo
BillionToOne , March 2022 $125m
BillionToOne logo
BillionToOne Series B round, July 2021 $55m
BillionToOne logo
BillionToOne Series A round, March 2019 $15m
BillionToOne logo
BillionToOne funding round, April 2019 $15m
BillionToOne logo
BillionToOne Seed round, September 2017 $2.4m
BillionToOne logo
BillionToOne Series C round, December 2022 $48.5m
BillionToOne logo
BillionToOne Seed round, August 2017 $120k
BillionToOne logo
BillionToOne Series A round, March 2020 $15m

Industries

BillionToOne is active in the following industries:
  • Biomedical engineering
  • Genomics
  • Engineering
  • Health technology
  • Healthcare
  • Genetic testing
  • Digital health
  • Medical diagnostics
  • Biology
  • Biotechnology
  • Technology
  • Molecular diagnostics
  • Molecular biology
  • Software as a service (SaaS)
  • Medical device
  • Health